Results 201 to 210 of about 5,286 (232)

RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells. [PDF]

J Transl Int Med
Dong XD, Lu Q, Li YD, Cai CY, Teng QX, Lei ZN, Wei ZH, Yin F, Zeng L, Chen ZS.   +9 more
europepmc   +1 more source

Evaluation of second-generation Bruton's tyrosine kinase inhibitors for the treatment of mantle cell lymphoma. [PDF]

J Oncol Pharm Pract
Lu J, Do B, Primeaux B, Primeaux B.
europepmc   +1 more source

Discovery of Reversible, Noncovalent Bruton's Tyrosine Kinase Inhibitors Targeting BTK C481S Mutation. [PDF]

ACS Med Chem Lett
Das D, Xie L, Qiao D, Cao Y, Jiang S, Zheng M, Liu Z, Li Y, Jia J, Lv Y, Hong J.   +10 more
europepmc   +1 more source

Expanded CD16⁺CD56⁺Granzyme B⁺ NK like CD8⁺ T cells an off target effect of bruton's tyrosine kinase inhibitors in Waldenström macroglobulinemia. [PDF]

Sci Rep
Hastak P, Phetsouphanh C, Zhang ZH, Bull RA, Shrestha LB, Klemm V, Louie R, Luciani F, Munier CML, Hoppé AC, Keoshkerian E, Beaton B, Rankin K, Wong A, Trotman J, Kelleher AD, Sasson SC.   +16 more
europepmc   +1 more source

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma. [PDF]

J Exp Clin Cancer Res
Wang J, Liu X, Hong Y, Wang S, Chen P, Gu A, Guo X, Zhao P.   +7 more
europepmc   +1 more source

Expression of Bruton's tyrosine kinase in osteoclasts

, 2016
Danks, L, Horwood, N
openaire   +1 more source

Molecular interactions of bruton's tyrosine kinase

openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bruton’s Tyrosine Kinase in Ankylosing Spondylitis

Spine, 2023
Study Design. Prospective case-control study. Objective. To explore the role of Bruton’s tyrosine kinase (BTK) in ankylosing spondylitis (AS). Summary of Background Data.
Hsien-Tzung, Liao, Chun-Hsiung, Chen
openaire   +2 more sources

Role of Bruton's tyrosine kinase in immunodeficiency

Current Opinion in Immunology, 1994
The genetic defect associated with human X-linked agammaglobulinemia and murine X-linked immunodeficiency was recently shown to result from lack of function of a new cytoplasmic tyrosine kinase, called Bruton's tyrosine kinase (Btk). The phenotypes associated with these immunodeficiencies indicate that Btk plays a critical role in B-lymphocyte ...
S, Tsukada, D J, Rawlings, O N, Witte
openaire   +2 more sources